Evotec SE (EVO) Goodwill & Intangibles (2009 - 2026)
Evotec SE (EVO) reported Goodwill & Intangibles of $357553.9 for Q1 2026, up 10.26% on a YoY basis from $324277.0 in Q1 2025, and down 99.89% sequentially from $317.4 million in Q4 2025.
Evotec SE (EVO) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 10 years of Goodwill & Intangibles data on file, last reported at $357553.9 in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 10.26% year-over-year to $357553.9; the trailing twelve-month figure through Mar 2026 stood at $357553.9 (up 10.26% YoY), and the FY2025 full-year result was $317.4 million, down 49.84% from the prior year.
- Goodwill & Intangibles declined to $357553.9 in Q1 2026, from $317.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $632.8 million in Q4 2024 to a low of $306669.7 in Q3 2022.
- A 5-year average of $130.9 million and a median of $347907.5 in 2025 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles jumped 102.04% in 2024 and tumbled 49.84% in 2025, its largest moves.
- Tracing EVO's Goodwill & Intangibles over 5 years: stood at $304.7 million in 2022, then rose by 2.79% to $313.2 million in 2023, then jumped by 102.04% to $632.8 million in 2024, then plunged by 49.84% to $317.4 million in 2025, then slumped by 99.89% to $357553.9 in 2026.
- Business Quant data shows EVO's Goodwill & Intangibles at $357553.9 in Q1 2026, $317.4 million in Q4 2025, and $351366.5 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357,553.92 |
| Dec 31, 2025 | 317.40 Mn |
| Sep 30, 2025 | 351,366.52 |
| Jun 30, 2025 | 344,448.54 |
| Mar 31, 2025 | 324,277.04 |
| Dec 31, 2024 | 632.77 Mn |
| Sep 30, 2024 | 324,925.81 |
| Mar 31, 2024 | 320,604.91 |
| Dec 31, 2023 | 313.19 Mn |
| Dec 31, 2022 | 304.68 Mn |
| Sep 30, 2022 | 306,669.66 |
| Mar 31, 2022 | 321,893.19 |
| Dec 31, 2021 | 329.94 Mn |
| Sep 30, 2021 | 338,379.99 |
| Dec 31, 2020 | 411.82 Mn |
| Dec 31, 2019 | 412.77 Mn |
| Sep 30, 2010 | 97,278.02 |
| Jun 30, 2010 | 2,182.52 |
| Mar 31, 2010 | 2,370.62 |
| Dec 31, 2009 | 67,290.35 |